BackNLS Pharmaceutics Overview

NLS Pharmaceutics Inventory

Track NLS Pharmaceutics's inventory ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00
↓ 100.00% YoYΔ $-297295.00 vs prior year quarter

Peer trimmed avg / median

Loading

NLS Pharmaceutics Inventory History

Loading

NLS Pharmaceutics vs. peers: Inventory Comparison

Loading

NLS Pharmaceutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NLS Pharmaceutics (NLSP) FAQ

NLS Pharmaceutics posts a inventory of $0 as of June 2025. That compares with $300K in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, NLS Pharmaceutics's inventory was $300K. The latest reading is $0 — a 100.0% year-over-year decrease (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of NLS Pharmaceutics's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NLSP's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NLS Pharmaceutics's other metric pages and overview cover the third.

Judging NLS Pharmaceutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in inventory easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.